You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Unlimited Prior Cytotoxic Chemotherapy Regimens

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Cancer of Gastrointestinal Tract Trial in Fort Worth (In-Person Exercise Protocol, Virtual Exercise Protocol)

Withdrawn
  • Cancer of Gastrointestinal Tract
  • In-Person Exercise Protocol
  • Virtual Exercise Protocol
  • Fort Worth, Texas
  • +1 more
Mar 23, 2022

Metastatic Colorectal Cancer, Colon Cancer, Rectal Cancer Trial (CTX-009)

Not yet recruiting
  • Metastatic Colorectal Cancer
  • +2 more
  • (no location specified)
Aug 22, 2022

Triple Negative Breast Cancer Trial (Camrelizumab?Capecitabine/eribulin/gemcitabine/vinorelbine,

Not yet recruiting
  • Triple Negative Breast Cancer
  • (no location specified)
Nov 22, 2021

NSCLC Trial in Seoul (SNK01 (Super Natural Killer Cells 01), GC, Cetuximab)

Recruiting
  • Non-small Cell Lung Cancer
  • SNK01 (Super Natural Killer Cells 01)
  • +2 more
  • Seoul, Songpa-gu, Korea, Republic of
    Asan Medical Center
Jul 15, 2021

Advanced Malignant Solid Tumor, Clinical Stage III Cutaneous Melanoma AJCC v8, Clinical Stage IV Cutaneous Melanoma AJCC v8

Recruiting
  • Advanced Malignant Solid Neoplasm
  • +28 more
  • Conroe, Texas
  • +4 more
Dec 5, 2022

Metastatic Breast Cancer Trial in China, Korea, Republic of, Taiwan (sacituzumab govitecan (IMMU-132), Eribulin Mesylate

Recruiting
  • Metastatic Breast Cancer
  • sacituzumab govitecan (IMMU-132)
  • +4 more
  • Beijing, China
  • +43 more
Apr 19, 2022

Advanced Cancer, Advanced Solid Tumor, Tumor Malignant Trial in United Kingdom (Fosifloxuridine Nafalbenamide, Leucovorin,

Not yet recruiting
  • Advanced Cancer
  • +16 more
  • Fosifloxuridine Nafalbenamide
  • +3 more
  • Birmingham, United Kingdom
  • +3 more
Feb 1, 2023

Mantle Cell Lymphoma, Non-hodgkin Lymphoma, Non Hodgkin Lymphoma Trial in Madison (Bendamustine, Obinutuzumab)

Recruiting
  • Mantle Cell Lymphoma
  • +2 more
  • Madison, Wisconsin
    University of Wisconsin Carbone Cancer Center
Sep 13, 2022

Metastatic Hormone-Sensitive Prostate Cancer Trial (Rezvilutamide, Rezvilutamide plus abiraterone, Continue previous treatment)

Not yet recruiting
  • Metastatic Hormone-Sensitive Prostate Cancer
  • (no location specified)
Nov 10, 2023

Lung Cancer, Small-cell Lung Cancer, Non Small Cell Lung Cancer Trial in Philadelphia (Carboplatin, Pemetrexed, Paclitaxel)

Recruiting
  • Lung Cancer
  • +2 more
  • Philadelphia, Pennsylvania
    Fox Chase Cancer Center
Mar 24, 2023

Adv Solid Malig - H&N SCC, ATM Pro / Def NSCLC, Gastric, Breast and Ovarian Cancer Trial in Worldwide (Administration of

Recruiting
  • Adv Solid Malig - H&N SCC, ATM Pro / Def NSCLC, Gastric, Breast and Ovarian Cancer
  • Administration of ceralasertib in combination with carboplatin
  • +3 more
  • Duarte, California
  • +26 more
Aug 17, 2022

Acute Myeloid Leukemia (AML), Myelodysplastic Syndrome (MDS), Hematopoietic Stem Cell Transplant (HSCT) Trial in Pittsburgh

Active, not recruiting
  • Acute Myeloid Leukemia (AML)
  • +2 more
  • Reduced-Intensity Conditioning Regimen
  • Myeloablative Conditioning Regimen
  • Pittsburgh, Pennsylvania
    UPMC Children's Hospital of Pittsburgh
Jan 4, 2023

Medical Oncology, Integrative Oncology, Medical Nutrition Therapy Trial in Buffalo (Diet)

Recruiting
  • Medical Oncology
  • +2 more
  • Diet
  • Buffalo, New York
  • +1 more
Jul 25, 2022

Adjuvant Chemoradiation of Gastric Carcinoma on Local Control

Not yet recruiting
  • Gastric Cancer
    • (no location specified)
    Mar 17, 2022

    Ovarian Cancer Trial in Worldwide (Alpelisib, Olaparib, Paclitaxel)

    Recruiting
    • Ovarian Cancer
    • Phoenix, Arizona
    • +116 more
    Nov 25, 2022

    Locally Advanced or Metastatic NSCLC Trial (Utidelone Injection, Docetaxel Injection)

    Not yet recruiting
    • Locally Advanced or Metastatic Non-Small Cell Lung Cancer
    • Utidelone Injection
    • Docetaxel Injection
    • (no location specified)
    Dec 30, 2022

    Triple-Negative Breast Cancer Trial in Guangzhou (DCb (docetaxel/carboplatin) versus EC followed by D

    Completed
    • Triple-Negative Breast Cancer
    • DCb (docetaxel/carboplatin) versus EC followed by D (epirubicin/cyclophosphamide followed by docetaxe)
    • Guangzhou, Guangdong, China
      Guangdong General Hospital
    Aug 27, 2022

    Cancer Trial in Rotterdam (Dexamethasone, H1 Antihistaminics)

    Not yet recruiting
    • Cancer
    • Rotterdam, Zuid-Holland, Netherlands
      Erasmus MC
    Nov 1, 2023

    Solid Tumor Trial in Japan (E7389-LF)

    Active, not recruiting
    • Solid Tumor
    • Kashiwa, Chiba, Japan
    • +11 more
    Nov 28, 2022

    Breast Cancer Metastatic, BRCA 1 Gene Mutation, BRCA 2 Gene Mutation Trial in Shanghai (SC10914)

    Unknown status
    • Breast Cancer Metastatic
    • +2 more
    • Shanghai, Shanghai, China
      Fudan University Shanghai Cancer Center
    Sep 18, 2020

    Metastatic Breast Cancer, Tumor, Muscle Tumors Trial in Colorado Springs (Method(s)1 Attribution, Method(s)2 Attribution,)

    Not yet recruiting
    • Metastatic Breast Cancer
    • +3 more
    • Method(s)1 Attribution
    • Method(s)2 Attribution,
    • Colorado Springs, Colorado
      PNAF Medical
    Nov 23, 2023

    Acute Lymphocytic Leukemia, Lymphoma Trial in New York (Biological/Genetically Modified T cells, Cyclophosphamide-based chemo)

    Active, not recruiting
    • Acute Lymphocytic Leukemia
    • Lymphoma
    • Biological/Genetically Modified T cells
    • Cyclophosphamide-based chemotherapy
    • New York, New York
      Memorial Sloan Kettering Cancer Center
    Jan 3, 2023

    Resectable Pancreatic Cancer Trial in Tianjin (AG Followed by FOLFIRINOX)

    Recruiting
    • Resectable Pancreatic Cancer
    • AG Followed by FOLFIRINOX
    • Tianjin, Tianjin, China
      Rui Liu
    Jan 8, 2023

    Breast Cancer Trial in Edmonton (Short-term diet and exercise intervention)

    Enrolling by invitation
    • Breast Cancer
    • Short-term diet and exercise intervention
    • Edmonton, Alberta, Canada
      University of Alberta
    Jan 4, 2023

    Acute Myeloid Leukemia Trial in NanJing (Homoharringtonine, Azacitidine)

    Recruiting
    • Acute Myeloid Leukemia
    • NanJing, China
      Department of Hematology, Zhongda Hospital, Medical School of So
    Sep 2, 2022